Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 3/20 | 0.38 |
| ▸ | BTK | Q06187 | 2/20 | 0.38 |
| ▸ | BRD4 | O60885 | 2/20 | 0.37 |
| ▸ | CDK2 | P24941 | 5/20 | 0.36 |
| ▸ | CDK9 | P50750 | 5/20 | 0.36 |
| ▸ | CCNT1 | O60563 | 4/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.36 |
| ▸ | ALK | Q9UM73 | 4/20 | 0.36 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | SYK | P43405 | 4/20 | 0.35 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | ITK | Q08881 | 1/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26619811 | 0.90 | JAK1 (0.39) | FLT3BTKBRD4CDK2CDK9 | |
| SCHEMBL26619900 | 0.89 | BRD4 (0.45) | FLT3BTKBRD4CDK2CDK9 | |
| SCHEMBL26619885 | 0.86 | BRD4 (0.39) | FLT3BTKBRD4CDK2CDK9 | |
| SCHEMBL26619973 | 0.83 | ALK (0.46) | FLT3BTKBRD4CDK2CDK9 | |
| SCHEMBL30670374 | 0.83 | ALK (0.46) | FLT3BTKBRD4CDK2CDK9 | |
| SCHEMBL26619908 | 0.73 | EGFR (0.49) | FLT3BTKBRD4CDK2CDK9 | |
| SCHEMBL30670358 | 0.73 | EGFR (0.49) | FLT3BTKBRD4CDK2CDK9 | |
| SCHEMBL26619865 | 0.73 | ALK (0.59) | BRD4CDK2CDK9CCNT1CCNE1 | |
| SCHEMBL26620627 | 0.73 | ALK (0.59) | BRD4CDK2CDK9CCNT1CCNE1 | |
| SCHEMBL30670360 | 0.73 | ALK (0.47) | BTKCDK2CDK9CCNT1CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023213211-A9 | 2,4-DISUBSTITUTED-5-FLUOROPYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF | 长沙晶易医药科技股份有限公司 | 2024-03-21 | — | — | WO | disclosed |
| WO-2023213211-A1 | 2,4-DISUBSTITUTED-5-FLUOROPYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF | 长沙晶易医药科技股份有限公司 | 2023-11-09 | — | — | WO | disclosed |